These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 9791689

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Association of nm23-H1 with orthopedic oncological conditions].
    Ha L, Guo W, Feng C, Li H.
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):477-9. PubMed ID: 11825445
    [Abstract] [Full Text] [Related]

  • 27. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M, Ralte A, Arora R, Santosh V, Shankar SK, Sarkar C.
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [Abstract] [Full Text] [Related]

  • 28. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J, Pavelic K.
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.
    Katsetos CD, Herman MM, Frankfurter A, Gass P, Collins VP, Walker CC, Rosemberg S, Barnard RO, Rubinstein LJ.
    Arch Pathol Lab Med; 1989 Sep; 113(9):1019-29. PubMed ID: 2505732
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lack of prognostic significance of nm23 expression in human primary breast cancer.
    Göhring UJ, Eustermann I, Becker M, Neuhaus W, Rein DT, Schöndorf T.
    Oncol Rep; 2002 Sep; 9(6):1205-8. PubMed ID: 12375020
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Survivin is a negative prognostic marker in medulloblastoma.
    Pizem J, Cört A, Zadravec-Zaletel L, Popovic M.
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
    [Abstract] [Full Text] [Related]

  • 39. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H, Korabiowska M, Brinck U, Trybus-Gałuszka H, Kellner S, Okoń K, Stachura J, Droese M.
    Pol J Pathol; 1998 Aug; 49(2):93-6. PubMed ID: 9798412
    [Abstract] [Full Text] [Related]

  • 40. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H, Mao H, Fu X.
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.